Google
×
Including results for sangamo investor relations
Search only for sgmo investor relations
Investor Relations/Media. Louise Wilkie. (628) 252-7840 · IR@sangamo.com · media@sangamo.com. Transfer Agent. Computershare, Inc. 250 Royall Street Canton, MA ...
The Investor Relations website contains information about Sangamo Therapeutics, Inc.'s business for stockholders, potential investors, and financial ...
People also ask
Sangamo Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Business Highlights ... Conference Call and Webcast Scheduled for 4:30 ...
BRISBANE, Calif. --(BUSINESS WIRE)--May 16, 2023-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced the appointment of ...
Access Sangamo Therapeutics Inc (SGMO) Investor Relations material, such as Live Earnings Calls, Transcripts, Slides, Reports, and Estimates using Quartr.
This information can be used by investors to verify and understand the financial position of the company. Many, but not all SEC filings are available in the ...
Nov 3, 2023 · Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q3 2023 Earnings ... I'm Louise Wilkie, Sangamo's Vice President of Investor Relations and Corporate ...
Nov 1, 2023 · SANGAMO THERAPEUTICS ANNOUNCES STRATEGIC UPDATE AND REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS. Contacts. Investor Relations & Media Inquiries
Investor Relations Intelligence. Featured Solutions. Nasdaq Boardvantage® · Board Evaluations · Nasdaq IR Insight® · Nasdaq Metrio · See All Solutions ->. About.
Head of Corporate Communications & Investor Relations Officer, N/A, N/A, N/A. Mr. Scott B. Willoughby, Senior VP, General Counsel & Corporate Secretary, N/A, N/ ...